Evaxion Biotech Company
Evaxion Biotech is devoted to the discovery and development of vaccines against cancer and infectious diseases.
Headquarters:
Copenhagen, Hovedstaden, Denmark
Industry:
Immunotherapy Development
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Investors Number:
2.0
Funding Status:
IPO
Technology:
Biotechnology
Last Funding Type:
Post-IPO Equity
Founded Date:
2008-01-01
Total Funding:
400000000
Last Funding Date:
2022-09-06